Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Remain Bullish on CrowdStrike Holdings with Increased Price Targets

Elaine Mendonca by Elaine Mendonca
March 6, 2024
in Breaking News
0
Software-solutions-technology
0
SHARES
23
VIEWS
Share on FacebookShare on Twitter

Catharine Trebnick, an analyst at Rosenblatt, has reiterated her Buy rating on CrowdStrike Holdings (NASDAQ: CRWD) and raised the price target to $400, up from $375. This adjustment signifies her optimistic view on the company’s future performance.

In a similar vein, Truist Securities analyst has also increased the price target for CrowdStrike Holdings to $350, further bolstering confidence in the company’s potential for growth.

CrowdStrike Holdings (CRWD) Stock Price Drops 5.18% on March 6, Pre-Market Trading Shows Potential for Recovery

On March 6, 2024, CrowdStrike Holdings (CRWD) experienced a significant drop in its stock price, with shares decreasing by $16.25 or 5.18% since the market last closed. Despite the drop in price during regular trading hours, CRWD saw a substantial increase in pre-market trading, with the stock rising by $66.94. CrowdStrike Holdings is a cybersecurity technology company that provides cloud-based endpoint protection. Investors and analysts will be closely monitoring CRWD’s performance in the coming days to see if the stock can maintain its momentum and continue its upward trajectory. Overall, while the drop in CRWD’s stock price on March 6 may have been a temporary setback, the subsequent increase in pre-market trading suggests that investors remain optimistic about the company’s future prospects.

CRWD Stock Surges on Strong Financial Performance and Growth Prospects in Cybersecurity Industry

CrowdStrike Holdings, Inc. (CRWD) has been making waves in the cybersecurity industry with its innovative solutions and strong financial performance. On March 6, 2024, the company’s stock showed impressive growth, reflecting its solid financial results.

According to data from CNN Money, CrowdStrike reported total revenue of $2.24 billion for the past year, representing a 54.4% increase compared to the previous year. In the third quarter alone, the company generated $786.01 million in revenue, marking a 7.43% increase from the previous quarter.

In terms of net income, CrowdStrike reported a net loss of $183.25 million for the past year. However, the company showed significant improvement in its financial performance in the third quarter, with a net income of $26.66 million. This represents a 21.96% increase compared to the previous year and a remarkable 214.74% increase from the previous quarter.

Furthermore, CrowdStrike’s earnings per share (EPS) also showed impressive growth on March 6, 2024. The company reported an EPS of -$0.79 for the past year, which increased by 23.96% compared to the previous year. In the third quarter, CrowdStrike’s EPS stood at $0.11, marking a substantial 212.57% increase from the previous quarter.

Overall, CrowdStrike’s stock performance on March 6, 2024, reflects the company’s strong financial results and growth prospects in the cybersecurity industry. With its innovative solutions, expanding customer base, and solid financial performance, CrowdStrike is well-positioned for continued success in the market. Investors may view CrowdStrike as a promising investment opportunity based on its impressive revenue growth, improving profitability, and strong earnings growth.

Tags: CRWD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Revolutionizing Fibromyalgia Treatment Tonix Pharmaceuticals and EVERSANA Partner to Launch Tonmya

Jefferies Analyst Upgrades Corbus Pharmaceuticals to Buy Raises Price Target

Analyst Raises Price Target for American Public Education to 15

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com